Haptena Therapeutics
Targeted immunotherapies
Founded 2025 · $3.5M raised
- Founded
- 2025
- Website
- haptena.com
- Total Funding
- $3.5M
- Last Round
- $3.5M SeedDec 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Haptena Therapeutics develops precision immunotherapies for genetically defined, oncogene-driven cancers. Its approach combines molecular-oncology, cancer-immunology, and translational-medicine research to understand how oncogenic drivers such as KRAS mutations shape tumor behavior and immune interactions. The company is building targeted treatment programs intended to overcome therapeutic resistance and create new options for patients with these tumors.
Summary
Haptena Therapeutics is a Biotech company, founded in 2025. It has raised $3.5M in total across 1 round, most recently a $3.5M Seed round in Dec 2025. Investors include Claris Ventures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2025
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/haptena-therapeutics"><img src="https://indexed.vc/api/badge/company/haptena-therapeutics" alt="Haptena Therapeutics on Indexed.vc" width="260" height="76" /></a>